Compare LyondellBasell Industries NV (LYB) vs Revvity Inc (RVTY) Price & Performance

LyondellBasell (LYB) trades at $60.36, up 3.19% today, showing mixed technical signals with a bearish overall trend but recent earnings beats. The company faces fundamental challenges with negative net income margin (-1.13%) and ROE (-3.19%) despite revenue stabilization around $30-31B. Recent dividend declaration of $0.69 per share provides income support while institutional activity shows mixed positioning with both increases and decreases in holdings.

Outlook remains cautious with analyst consensus at $69.38 target (15% upside) but divided ratings (45% Buy/45% Hold). Key risks include cyclical chemical demand, margin pressure from Middle East supply normalization, and declining operating cash flow trends. The stock offers value through low P/S (0.62) but requires earnings recovery to justify current valuation multiples.

RVTY trades at $152.16, down 0.94% on the day, but maintains a bullish technical trend with strong moving average signals and support near $149. The company has consistently beaten earnings estimates in recent quarters, with Q3 2026 results expected soon. Revenue remains stable around $2.9 billion, though net income margins have softened slightly. Recent news highlights product launches and strategic acquisitions, such as the Human Cell Design deal, to bolster its life sciences portfolio.

The outlook is supported by analyst optimism with a 51.72% buy rating and a consensus price target of $132.13, though the current price trades above this target. Key risks include premium valuation metrics, margin pressures, and exposure to macroeconomic headwinds. The stock's proximity to its 52-week high suggests momentum but warrants caution given rich multiples.